These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 14966870)

  • 41. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes.
    Geirsson A; Bothwell AL; Hammond GL
    J Heart Lung Transplant; 2004 Sep; 23(9):1077-81. PubMed ID: 15454174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
    J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
    Collinge M; Pardi R; Bender JR
    J Immunol; 1998 Aug; 161(4):1589-93. PubMed ID: 9712019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V; Mach B; O'Reilly R; Lee JS
    J Immunol; 1997 Aug; 159(3):1086-95. PubMed ID: 9233601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pRB is required for interferon-gamma-induction of the MHC class II abeta gene.
    Zhu X; Pattenden S; Bremner R
    Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell expression of CIITA represses Th1 immunity.
    Park WS; Bae Y; Chung DH; Choi YL; Kim BK; Sung YC; Choi EY; Park SH; Jung KC
    Int Immunol; 2004 Oct; 16(10):1355-64. PubMed ID: 15351782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.
    Beresford GW; Boss JM
    Nat Immunol; 2001 Jul; 2(7):652-7. PubMed ID: 11429551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
    De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS
    Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.
    Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG
    Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
    LeibundGut-Landmann S; Waldburger JM; Reis e Sousa C; Acha-Orbea H; Reith W
    Nat Immunol; 2004 Sep; 5(9):899-908. PubMed ID: 15322541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
    LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
    Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
    He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
    J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
    J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.